Top 50 Biotech Startup Investors in Germany (September 2026)

Portfolio highlights

• Zimory — Founded in 2007, Zimory provides carrier-grade cloud infrastructure management software that allows service providers, enterprises and cloud brokers to fully leverage the power and elasticity of cloud computing. Zimory’s intelligent Cloud Suite simplifies, automates and expedites the creation, launch and management of all types of cloudenvironments – whether public, private, virtual private or hybrid. Zimory software is also a key enabler of cloud marketplaces for enterprise services, applications and infrastructure. Headquartered in Berlin, Zimory has development centers in Erfurt, Germany and Minsk, Belarus, a subsidiary office in New York City and is expanding its expertise and presence globally.
• Alteva — Alteva develops battery cells for the decarbonisation of the global transport sector, and focus on high-energy density battery cells with high safety profiles specifically designed for the aviation and heavy-duty transport sectors.
• Smartblue — Smartblue develops and runs software and processes to monitor and optimize zero emission energy systems. As a hardware independent specialist Smartblue delivers a software service for the maintenance, life-cycle management, production forecasting and remote control of photovoltaic and energy storage systems all together in one centralized “SmartControl” Operations and Control Center web application. We help our customers drive down overall operational cost through automation, smart failure detection and big data analysis on imminent defects.

Portfolio highlights

• Hema.to — Flow cytometry analysis software, re-imagined. From raw FCS and LMD data to finalized report with AI-powered CellStudio.
• 4.screen — The Driver Interaction Platform. Connect with drivers in real-time to deliver personalized and targeted campaigns.
• inContAlert — inContAlert is a deep tech start-up disrupting the field of incontinence. The technology of inContAlert helps people with bladder dysfunction to monitor the filling level of their urinary bladder.inContAlert, therefore, developed an mHealth device, which collects and analyzes data with the help of deep learning algorithms. The information is thendisplayed on an app and sends an alert to incontinence patients when a predefined filling level is reached. inContAlert thereby minimizes the risk of an uncontrolled loss of urine or the harmful distension of the bladder. With the help of inContAlert, incontinence patients can go back to normal and live a carefree life.

Portfolio highlights

• Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
• smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
• Cloverleaf Bio — Cloverleaf Bio | Developing a new class of RNA therapeutics to revolutionize cancer therapy.

Portfolio highlights

• skylance — Skylance develops counter-unmanned aerial systems for military and public-security users. Its products include close-range kinetic interceptors designed for Class 1 drones and a modular launcher that supports shoulder-mounted, tripod, and vehicle-integrated configurations. The company describes its systems as software-defined and compatible withexisting command-and-control structures. Its stated operating range for close-range interception is 100 to 1,200 meters.
• OMMM — OMMM Operations Management Solutions is a software house that specializes in the digitization and automation of industrial planning.
• PhageStack — PhageStack GmbH develops a computational platform that applies machine learning to screen, identify, and analyze specific bacteriophages. This technical infrastructure is built to help research partners accelerate the discovery of targeted biological options against antibiotic-resistant bacteria.

Portfolio highlights

• Andercore — Andercore connects global suppliers and local buyers on one AI-driven platform, automating inventory selection, pricing, quotes, financing and global distribution at scale.
• AtlasEdge — Empowering a sustainable digital society by enabling infrastructure where it is needed.
• Quantum Systems — Our vision is to become the global leader in providing aerial data for decision making by the use of our drones.

Portfolio highlights

• NcodiN — The High Performance Computing (HPC) and ArtificiaI Intelligence (AI) era requires unprecedented computing capabilities. With this in view, industry is heading towards zettascale supercomputers, based on >100k processing units. Chiplets-based disaggregated processors and memory-centric computing architectures are taking over and require an ever more intensive communication between dies. Thus, today interconnect bottleneck is the main
• GlassPoint Solar — GlassPoint provides solar steam generators to the oil and gas industry for applications such as Enhanced Oil Recovery. It replaces gas-fired steam generation with solar, GlassPoint can reduce EOR gas consumption by up to 80 percent. The company was founded in 2008 and headquartered in Fremont, California.
• Zadient Technologies — Zadient produces semiconductor manufacturing materials that are critical for the entire silicon carbide (SiC) value chain

Portfolio highlights

• Prodlane — Prodlane, the company behind MAIA, is a technology company based in Leipzig that specializes in intelligent software solutions for SMEs in the DACH region. With MAIA, we are setting new standards in data analysis and daily knowledge management in all areas of the company using AI, thereby driving forward the digital transformation of SMEs.
• Cyber Insight — Cyber Insight - Measure, Manage, Mitigate Cyber Risks
• HandsOn Robotics — Handson Robotics provides state of the art robotics automation workflows for commercial kitchens.

Portfolio highlights

• nyra health — nyra health is an artificial intelligence and evidence-based neurological research tablet app that offers a revolutionary form of therapy. nyra health was founded in 2020 and was headquartered in Vienna, Austria.
• Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
• Beren Therapeutics — Founded to serve patients through transformative medicines

Portfolio highlights

• mo:re GmbH — We offer standardized tissue cultures and protocols to better predict drug responses and investigate disease models.
• Atrya — Atrya develops regulatory-compliant blockchain payments for international companies.
• DEALCIRCLE — DealCircle is a digital M&A solution and partner of hundreds of M&A advisors. We support in identifying buyers and addressing the market. This provides investors access to a comprehensive deal flow of relevant projects.

Portfolio highlights

• T-CURX — T-CURX develops a new generation of T cells for personalized cancer immunotherapy, built on a proprietary platform that overcome challenges ...
• iDEL Therapeutics — iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.
• ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.

Portfolio highlights

• Nenna AI — Nenna AI is a powerful AI enablement platform designed for the secure application of AI technologies.
• Jurafuchs — Jurafuchs provides legal education via a mobile app.
• AERLIN — AERLIN GmbH is an innovative aerospace technology company based in Berlin, Germany, focused on designing and manufacturing a next-generation flying-wing aircraft platform. The company aims to transform regional and light aviation by moving away from traditional tube-and-wing designs. Instead, they use a highly efficient airframe architectureinspired by the aerodynamic principles of the albatross. Their scalable platform is engineered to support clean propulsion technologies—including Sustainable Aviation Fuels (SAF), hybrid systems, and battery-electric power—without compromising payload volume, cruise range, or passenger comfort.

Portfolio highlights

• Sourcepulse — Your early warning system for software delivery (YC S23)
• Open Cosmos — Open Cosmos design, build and operate space missions, providing straightforward access to high quality satellite data and insights on a global scale.
• HelmGuard AI — HelmGuard develops an AI-driven trust infrastructure platform for security, compliance, and third-party risk management. The company provides an operational risk infrastructure layer that centralizes fragmented security, compliance, and vendor data into a structured repository. Its platform coordinates autonomous, domain-specific AI agents thatperform continuous data indexing, compliance mapping, automated vendor assessments, and real-time security tracking. HelmGuard includes a risk operating system, a zero-knowledge verification engine for selective disclosure and cryptographic-style proofs, and persona-specific risk intelligence reporting. These capabilities support first-party, third-party, and customer-facing workflows across sectors such as financial services, SaaS, and healthcare. The platform is used by security, risk, and compliance teams to maintain continuous oversight of internal controls, vendor posture, and regulatory obligations while generating tailored, natural-language reports for business stakeholders.

Portfolio highlights

• PL BioScience — STEM CELL EXPANSION IN SAFE AND REPRODUCIBLE CONDITIONS. We deliver advanced 2D and 3D cell culture solutions based on human Platelet Lysate – for basic research, cellular therapeutics and clinical applications. Choose between different safety grades meeting your needs: Research Grade, GMP Grade or GMP-Clinical Grade.
• Cultimate Foods — At Cultimate, we are transforming the flavor and aroma industry with natural innovative ingredients.
• traceless materials — traceless materials offer a holistically sustainable alternative to plastics: 100% biobased on plant residues, compostable under natural conditions, and free of toxic chemicals. For a future free of pollution and waste!

Portfolio highlights

• Fly.io — Build fast. Run any code fearlessly.
• Einride — Einride designs state-of-the-art supply chain technology for global industries that want to lower emissions and increase efficiency.
• Syntetica — Syntetica is a materials technology and climate technology company that develops chemical recycling technology for synthetic textiles. It uses proprietary green chemistry to convert nylon textile waste into virgin-quality recycled polymers, enabling circular production for the textile, automotive, and industrial materials industries. Its mission isto decarbonize synthetic materials by making high-quality recycled feedstocks commercially viable.The company's proprietary chemical depolymerization process separates and recovers Nylon 6 and Nylon 6,6 from blended textile waste that would otherwise be difficult to recycle. The process operates under low-temperature, low-pressure conditions, removes dyes and finishes, and produces recycled raw materials that can be reintroduced into manufacturing without compromising quality. Syntetica's technology supports textile-to-textile recycling and is designed to reduce carbon emissions, landfill waste, and reliance on virgin fossil-based materials.

Portfolio highlights

• Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
• Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
• Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.

Portfolio highlights

• Streaming21 — Streaming21 is a solution provider of seamless on-demand and IP broadcasting service platform for connected digital home.
• Helomics — Helomics® is a comprehensive personalized healthcare company, bringing the next generation of diagnostics to the oncology field. Helomics is dedicated to improving patient outcomes by providing a personalized comprehensive tumor profile utilizing a proprietary set of laboratory platforms that leverage both tissue-based live and fixed cellular basedanalysis allowing physicians to characterize malignant tumors on a personalized basis. Helomics’ novel molecular and cellular markers and bioinformatics services support treatment decisions by providing vital information based on the specific biological processes of each individual’s cancer.
• Precision Therapeutics — Precision Therapeutics is a pharmaceutical research and development business that develops personalized cancer treatments for patients.

Portfolio highlights

• Arsanis — Arsanis is a clinical-stage biopharmaceutical company focused on applying monoclonal antibody (mAb) immunotherapies to address serious infectious diseases. A deep understanding of the pathogenesis of infection, paired with access to some of the most advanced mAb discovery techniques and platforms available today, has positioned Arsanis to build andadvance a pipeline of novel mAbs with multiple mechanisms of action and high potency against their intended targets.The company’s lead clinical program, ASN100, is aimed at serious Staphylococcus aureus infections and is being evaluated in Phase 2 clinical trial for the prevention of S. aureus pneumonia in high-risk, mechanically ventilated patients. In addition to ASN100, its preclinical pipeline is comprised of mAbs targeting multiple serious bacterial and viral pathogens, including respiratory syncytial virus.Arsanis is a U.S. company headquartered in Waltham, Massachusetts, with European research and preclinical development operations headquartered in Vienna, Austria (Arsanis Biosciences GmbH).
• Topas Therapeutics — Topas Therapeutics GmbH is a private Hamburg, Germany-based biotechnology company focused on developing products to address areas of major unmet need, including autoimmune diseases, allergies and anti-drug antibodies. The Topas Particle Conjugates technology platform induces antigen-specific immune tolerance by harnessing the liver’s naturalimmunology capabilities. The Company has several proprietary programs; lead product candidate TPM203 has recently entered clinical testing for pemphigus vulgaris, an orphan disease. Other programs are in anti-drug antibodies, celiac disease, Type 1 diabetes, as well as a multiple sclerosis program that is available for partnering.Topas has a research and option agreement with Eli Lilly and Company focused on antigen-specific tolerance induction and a multi-year agreement with Boehringer Ingelheim to collaborate in the field of anti-drug antibodies.Topas’ investors include: Epidarex Capital, Gimv, EMBL Ventures, Evotec and Boehringer Ingelheim Venture Fund.
• Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.

Portfolio highlights

• Kupando — Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.
• AssistMe — With a smart, adaptive and automated form of data processing and preparation, alea opens the way for future-proof, digitally supported everyday care. As an initial component of the AssistMe care platform, alea enables a contemporary, efficient care data culture for future intersectoral, networked processes and digitally supported teamwork. In theend, the aim is to effectively support care in times of a shortage of skilled workers through more self-determined content transparency - with complete personal autonomy and freedom of action and less redundancy & stress.Elderly Care will struggle in the next 10 years due to an increasing ageing population, fewer caregivers, more workload, stress, and manual documentation. All of that is a problem for the well-being of those in need of care. Furthermore, the incontinence management means large time and material expenses for caregivers. With the joint system, both companies can equip over 80 % of care recipients in care homes. An initial scientific study proved that the system could save 23 % of adult diapers and time while changing them. Together with significantly fewer leakages, the caregiver can reinvest the time gained in even higher quality care work. This ultimately has the potential to benefit care recipients in terms of quality of sleep and life. Digital functions for optimized care processesWith a very new smart sensor strip, we made leading quality adult diaper brands compatible with the digital possibilities of intelligent care technology of alea. The system reveals where care needs exist, but are not immediately visible, e.g. the urine status in the adult diaper which previously was not known until manually checked. The system transforms this initially hidden care and health data and converts it into digital, structured, immediately understandable real-time information for elderly care and its relevant stakeholders. All functionalities are based on the device alea sensor clip on smart Diaper products, which can be attached and changed in seconds. With just one quick click, caregivers turn the smart diaper into a ready-to-use digital care assistance system. With an optimal sensor position in the centre of the adult diaper and without direct skin contact. The alea hardware can generate highly valid information and make it available to care staff in real time through the mobile and web apps. The care-relevant information of alea includes the amount of urine, movements in the care bed for effective pressure ulcer prevention, fall detection and zone management. How caregivers, care homes & care recipients benefitOver 80 % of care home residents suffer from incontinence. This is a major challenge for everyone involved. The smart system solves issues for all care related audiences: Care recipients benefit from less time in full incontinence pads, but also benefit from fewer manual visual checks during bedtimes. In addition, there is a higher level of safety and prevention. By reducing time-consuming routine and visual checks on an as-needed basis. Caregivers can invest the time gained in other important or relevant care tasks. In this way, they can increase their self-determination in their work and thus their job satisfaction. Thanks to the significant savings in materials and costs, care home operators gain more planning security and can focus their business value creation even better on direct care for people in need of care. In this way, care homes can position themselves as more attractive employers for care staff because they have state-of-the-art digital equipment.With the Care. For the Care. The solution was developed and tested together with the care practice. With the IoT and future-proof platform approach, caregivers will benefit from additional functions in an established and accepted product setting. The system can be connected to various care documentation systems via open interfaces. The aim of the solution is not only to reduce the workload for all those involved in care. Care homes can also optimize teamwork and automate routine processes to support caregivers in the interests of people-centric care in the face of an increasing shortage of skilled staff. With the market entry, care homes can obtain information and order from us or one of our partners. While they order smart Diapers from our partners in the unit price context they are used to, alea Digital System comes as a software-as-a-service model. Without any additional initial costs, they can use all functions via personally provided hardware and software for each care recipient – for the most cost-efficient and needs-orientated use.
• All About Accuracy — Sub-1mm accuracy and <1ms latency RF localization for physical AI. Train robots with ground-truth motion data cameras and GPS can't reach.

Portfolio highlights

• Finoa — Finoa is the leading European crypto-asset management platform, empowering businesses and institutions to engage with crypto safely and intuitively.
• Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
• Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and

Portfolio highlights

• Altavo — Altavo operates as a medical device startup. Altavo harness the power of machine learning and state-of-the-art sensor technology to improve the lives of people who have lost their voice.
• Peeriot — Peeriot is a B2B software high-tech startup with a breakthrough in IoT. Peeriot offers a low-code software suite that simplifies IoT data sharing by tenfold.
• warmwind — warmwind is your all in one solution, when it comes to AI workers. No more tool chaos - everything in the cloud.

Portfolio highlights

• Lab Thunder — LabThunder provides a cloud-based laboratory management software platform designed to digitize operational workflows. The system centers on centralizing equipment management, automated maintenance scheduling, digital logbooks, and AI-supported knowledge management to ensure audit-ready compliance.
• Sedivention — Fight obesity within 20 minutes - fast, effective, long-term. A new weight-loss therapy for the treatment of obesity. Just a view minutes will change your life.
• Solar Materials — Solar Materials primarily engages in the development of technologies for the sustainable and economical recycling of solar modules.

Portfolio highlights

• Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
• Solstice Oncology — Solstice Oncology is a clinical stage immuno-oncology company developing a therapeutic that meets cancer at its most vulnerable moment, before surgery, to drive deep pathological response and return patients to lasting health. The company's lead program is targeting colon cancer.
• Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.

Portfolio highlights

• VisioLab — Instantly scan products for self-checkout, using the iPad camera - no barcodes needed. Designed for speed, simplicity and human centricity.
• Pacifico Biolabs — Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of sustainable and food alternatives.
• dsb Deutsche Sanierungsberatung — dsb Deutsche Sanierungsberatung provides easy and sustainable solutions for climate-friendly homes energy-efficient renovations for homeowners.

Portfolio highlights

• SonoBeacon — SonoBeacon is an integrated software, hardware and platform solution provider. SonoBeacon's services enable companies to communicate directly with end users by delivering content to an end user's mobile device through ultrasound-based technology and interaction with a SonoBeacon-powered platform.
• Evertracker — Evertracker provides the first Neutral and Smart Control Tower for Global Supply Chains that enables manufacturers and producers to get end-to-end visibility and predictability of their global supply chains. The platform provides the transparency on an item level, which enables our users to not only know where their shipments are but what partswill be delayed or have issues. Thus they can plan their production more reliably.
• Innocent Meat — Innocent Meat turns food producer in cell-based meat producers by developing an automated end-to-end clean meat production system.

Portfolio highlights

• socialhub — Boost your social media success with SocialHub. Manage channels, schedule posts & get meaningful analytics. Try it out now!
• SPiNE — SPiNE is a startup that provides safe, clean, and inexpensive energy to all end users. It is focused on smart meter rollout and, as a result, digitalization in metering and control of charging infrastructure, heat pumps, and battery storage.
• TalentRocket — Talent Rocket is a job search engine that enables its users to find jobs with a suitable work environment for them. Job seekers can select their preferred company culture, follow their favorite companies, and start career conversations with employers. Talent Rocket was founded in 2014 and is based in London, United Kingdom.

Portfolio highlights

• Credoxys — Credoxys develops organic electronic materials for OLED displays, OLED lighting, organic photovoltaics, and sensors. Its portfolio includes dopants and transport materials designed to influence charge transport, optical transmission, power consumption, and energy generation in organic electronic devices. The company also develops materials forscale-up and customer-specific applications.
• Dawnguard — AI-native platform for fast cloud design and implementation.
• QuoIntelligence — Our finished intelligence will significantly reduce your operational risks and allow you to make informed security decisions.

Portfolio highlights

• Shippn — International package forwarding service. Shop from Amazon, Shein, Macy's worldwide. Fast shipping with DHL & FedEx. Trusted by 50,000+ customers.
• heybooster — heybooster is the creator of a platform for marketing analysis that aids e-commerce managers in finding chances for revenue growth and in making better choices. It provides clients with digital reporting, online meetings, online communication, an online project management system, and an online playbook that helps them discover problems, findpossibilities for revenue growth, and cut expenses.
• Mars Studios — Mars Studios is an experienced team of growth hackers & marketers that can help you to increase your revenue. Rocket Your App to Success: Mars Studios

Portfolio highlights

• Q.ANT — Q.ANT develops photonic processors for AI and high-performance computing, utilizing light for information processing. The company also produces quantum sensors offering ultra-high magnetic field sensitivity in a compact form factor. These products aim to enable more intelligent and sustainable systems across various sectors like data centers,aerospace, and medical technology.
• XO Life — XO-Life.com is an online destination center. That provides services includes digital treatment monitoring and patient feedback R&D, marketing and sales. That offers services for Patient Insights, information exchange between patients and pharma, treatments and indications.
• Patronus Group — Rethinking elderly healthcare

Portfolio highlights

• Silexica — Silexica was a venture capital backed company for software development tools. The SLX programming tools accelerate the journey from software to application-specific hardware systems and thus reduce time-to-market of intelligent products.Founded in 2014 as a spin-off from RWTH Aachen University, Silexica was headquartered in Germany with officesin the US and Japan. It has received $28M in venture capital funding from international investors and was acquired by Xilinx/AMD in 2021.
• Cube Sports — Cube Sports operates kids, teens and adults sporting products.
• Vimecon — Vimecon develops and produces laser catheters for the treatment of heart diseases with a focus on atrial fibrillation. It also manufactures products for the medical technology and biotechnology; and offers microscopically small catheters, as well as micro materials handling techniques for exact measurement and dosage. Moreover, Vimecon advisesvarious customers from the scholar and industrial research and development. Kai U. Markus founded it in 2005, with its headquarters in Herzogenrath in Germany.

Portfolio highlights

• Octonomy — octonomy: AI-as-a-Service mit der neuen Generation von KI-Agenten. 80 % Zeitersparnis, 24/7-Support in 30+ Sprachen, live in 20 Tagen.
• Wakeline — Wakeline builds the missing half of AI: continual learning that adapts in operation, staying aligned as conditions change. Market Edge delivers adaptive day-ahead price forecasts for European BESS operators.
• specter automation — Construction is the second least digitized sector in the world with 96% of all data being unused. Although detailed planning data is created upfront, a lack of suitable digital tools prevents its transfer to the construction site. SPECTER’s web-based construction management software uniquely incorporates the core components of constructionplanning, reducing the organizational burden on construction management and helping to meet project timelines and budgets.

Portfolio highlights

• Dermanostic — Dermanostic is an e-health app where patients receive a medical diagnosis and therapy recommendation for skin diseases.
• Dr. Vivien Karl — Dr. Vivien Karl is an intimate care company. Dr. Vivien Karl provides science based products for effective and safe intimate care. Their products include cream for moisturizing and caring for the intimate area.
• microsynetics GmbH — Developing hardware and software to help elderly people gaining more freedom and quality of life. Our first product is an emergency wristband which works together with an app, also connecting relatives via smartphone and phone integrated in the emergency wristband. The automated AI-based fall detection guarantees help even when the user - afteraccident - isn't capable anymore of activating the emergency call via integrated button.

Portfolio highlights

• Ekstere — Ekstere facilitates selling and purchasing verified-quality used bicycles at a reasonable price.
• Presto Engineering — We enable companies imagine and implement microelectronics solutions in high-value markets such as Industrial, Automotive, Communication and Medical.
• Vertero — Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.

Portfolio highlights

• Calibre — Diagnostic testing, clinicians, and AI working together to help you deeply understand your health and how to improve it.
• Modern Relay — Modern Relay provides context graph for enterprise AI.
• Tandem Health — Focus on providing care, while Tandem helps you easily write medical notes directly after the patient consultation.

Portfolio highlights

• Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
• Muna Therapeutics — Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
• HotSpot Therapeutics — HotSpot Therapeutics is a biotech startup that focuses on the development of allosteric therapies targeting regulatory sites on proteins. It develops a therapy platform to discover medicines and provide proper treatment to identify hotspots and locate pathway treatments for cancer, metabolic and rare diseases, leverages a database of hotspotstructures, harnessing the power of data science in its multidisciplinary approach to drug discovery, and helps patients to get treatment against several diseases.HotSpot Therapeutics was founded in 2017 and is headquartered in Boston, Massachusetts.

Portfolio highlights

• ChemInnovation — Molecules from Spectra - For a World without UnknownsAs ChemInnovation, we work on innovative & tailored AI-solutions for analytical chemistry. Within our first years as a company, we were able to bring our intelligent software METIS to researchers and partners within renowned chemical companies. Our smart software METIS accelerates theresearch and development of our customers. Therefore, it empowers them to accelerate their research, understand their chemistry and make their products safer. To achieve this, we have developed our own chemically inspired AI models and smart algorithms, which we now use to automatically evaluate complex data. We combine know-how from the chemical and computer science worlds thereby translating results from academia into productive cloud-software.
• Circus Group — At Circus, we believe cooking should be a loved hobby but not a daily necessity. Driven by the mission to fuel people's busy every day we are building a radically more convenient, sustainable, and affordable solution in food delivery. Circus was established in 2021 in Hamburg, Germany.
• Rock Tech Lithium — Rock Tech Lithium Inc. is a mineral exploration company focused on the lithium industry. Based in Vancouver and listed on the TSX Venture Exchange and the Frankfurt Stock Exchange, the Company’s international board of directors provides a truly global presence and offers unique access to capital and projects.The Company holds an interest in theGeorgia Lake lithium project in the Thunder Bay Mining District of Ontario. The Georgia Lake project consists of approximately 80 leases and approximately 20 claims covering approximately 4,590hectares. The project is located in an area underlain by metasediments and metavolcanics of Archaen age. The Georgia Lake pegmatites contain lithium-bearing spodumene. The spodumene-bearing pegmatites of the Georgia Lake area are located approximately 140 kilometers northeast of the city of Thunder Bay.

Portfolio highlights

• Mkind — Mkind builds intelligent robots for high-mix manufacturing, developing advanced automation solutions that can adapt to diverse production requirements, improve operational efficiency, and support manufacturers in handling complex, low-volume, and frequently changing product lines.
• Orbem — Transform biological imaging with AI-powered MRI technology. Non-invasive solutions for poultry, fruits, nuts, and health. Building a sustainable future.
• Transition Metal Solutions — Transition harnesses wild microbial communities to recover copper and other critical metals from low-grade mining resources.

Portfolio highlights

• Cyllene Therapeutics — EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.
• Inventiva Pharma — Inventiva Pharma is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical needs in the areas of fibrosis, lysosomal storage disorders and oncology.They have built a pipeline backed by a discovery engine with an extensive library ofproprietary molecules, a wholly-owned research and development facility and a team with significant expertise and deep experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging these assets and expertise, they are advancing two clinical candidates in three indications, as well as a deep pipeline of earlier stage programs.
• Rivermark Medical — Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function. Developed by urologists to reliably reduce BPH symptoms with minimal side effects.

Portfolio highlights

• Fiagon — Fiagon develops clinical navigation systems that reimagine image guidance by improving the function of electromagnetic navigation. Fiagon's systems use electromagnetic tracking matrix algorithms and flexible pointer technology that indicates the position of the instrument used in the CT or MRI image data, allowing physicians to get accurateplanning, improve patient outcomes, and implementation of the operation.
• Meidrix Biomedicals — Meidrix Biomedicals is a medical biotechnology company that specializes in medical devices for cartilage repair. Meidrix Biomedicals also offers regenerative and biological medical products. Meidrix Biomedicals was founded in 2009 and was headquartered in Bayern, Germany.
• SurgicEye — SurgicEye designs intra-operative imaging and instrument navigation solutions for surgical procedures. It offers a navigated radio-guided surgery based on the handheld 3-D freehand SPECT imaging technology called the declipse SPECT open surgery, an intraoperative 3D imaging system for invasive sentinel lymph node biopsy called the declipse SPECTLaparascopy, and a mobile SPECT imaging solution with a high resolution on a small footprint called the declipse SPECT imaging probe. The company also advises clients on medical device development, requirement engineering and software specification for medical devices, software development for medical devices, testing of software for medical devices, and support in the design and conduction of clinical studies.Dr. Jörg Traub founded SurgicEye in 2008, with its headquarters in Munich in Germany.

Portfolio highlights

• Innovacell — Innovacell is a biotechnology firm entirely focused on the area of tissue engineering and it operates one of Europe's largest and most modern production facilities for the proliferation of the body's own tissue cells. Its supervisory board is chaired by the experienced financial expert, Dr. Harald Pöttinger, a director of Alpine EquityManagement AG, based in Bregenz, Austria. Innovacell currently employs 20 staff as well as numerous outside experts.
• Project Eaden — PROJECT EADEN combines pioneering technology and engineering expertise with an immense love for food and lust for life. For full indulgence. With zero guilt.
• Epoch Biodesign — Mellizyme Biotechnology is currently operating in stealth.

Portfolio highlights

• Hemispherian — Hemispherian is an innovative preclinical pharmaceutical company focused on developing a novel class of small molecule drugs. These drugs target the TET2 enzyme as an epigenetic therapy for particularly aggressive cancers.
• Atriva Therapeutics — Therapies against viral infections. First-in-class host-targeting therapies to treat respiratory viral infections, including COVID-19 and influenza.
• Tagworks Pharmaceuticals — As pioneers of Click-to-Release technology, we are revolutionizing cancer treatment using in vivo click chemistry to increase the therapeutic window of powerful cancer therapies.

Portfolio highlights

• yasp — Agentic optimized GPU code and full-model compilation for NVIDIA, AMD, and edge silicon. You choose the hardware, yasp handles the rest.
• Pionix — PIONIX develops EVerest, a fully featured commercial open source SW platform for charging stations. With our open platform, we will provide a broad ecosystem for EV charging that can be easily extended by the open-source community and utilized by any commercial party.PIONIX as main developer of the EVerest ecosystem offers integration andsoftware update services, cloud operations and productivity & security enhancements as subscriptions.
• Computomics — Computomics is a team of world-leading experts in plant research and bioinformatics, offering next-generation sequencing (NGS) analyses for agriculture biotech companies and crop scientists. Whether you are concerned with crop improvement, seed production or plant protection, Computomics helps navigate the complexities of grain, vegetable, fruitand other genomes. Our advanced bioinformatics services provide our customers with quality NGS data interpretation from state-of-the-art genomics tools and technologies. Let us help you achieve your research goals.

Portfolio highlights

• Wandercraft — Self- balancing and hands free movement with the innovative self-balancing feature, Atalante allows for multi-tasking and cognitive involvement as part of treatments.
• Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
• Skyborn Renewables — Skyborn Renewables develops, builds, and operates offshore wind projects across the full lifecycle. The company identifies sites, secures permits, structures financing, and manages engineering, procurement, and construction. Its teams plan grid connections and deliver operations and maintenance for utility-scale assets. Skyborn Renewables alsoprovides asset management, health and safety oversight, and environmental monitoring throughout project life. Services include offtake strategy and power sales support, stakeholder engagement, and supply chain coordination. The portfolio covers greenfield development, joint ventures, and acquisitions, with capabilities from early-stage studies to long-term operation. Technology work spans turbine selection, foundation design, cable layout, and digital performance analytics. Skyborn Renewables collaborates with partners to expand renewable generation and enable electrification through offshore wind energy.

Portfolio highlights

• Everlab — The preventative health service of the future. Detect disease early, improve wellbeing, and optimise performance.
• Flyboard — Human-level AI voice agents at a fraction of the cost. Transform your customer engagement with intelligent automation.
• Kiin Bio — Accelerate drug discovery with Virtual Scientists. Unified platform integrating 100+ specialized tools into one intelligent workflow.

Portfolio highlights

• Shiru — Discover Shiru. We are an Ingredient Company that Identifies and Creates Functional Ingredients for the Plant-Based Industry.
• Xias Bio — Mitigate risk with flexible licensing options. Partner with us to transform your ideas into high-performance innovations optimized for efficacy and differentiation.
• Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.

Portfolio highlights

• Meatable — Meatable is a food production company that produces guilt-free meat. Meatable is a company that creates manufactured meat using stem cell technology. By employing pluripotent stem cells, which have the potential to transform any type of cell from muscle to fat without serum, the company's method eliminates the need to remove any tissue from ananimal, allowing consumers to have sustainable food.
• SuperMeat — SuperMeat is an Israeli bio-tech and food-tech company, developing a technology to create clean meat from chicken cells in a safe and controlled environment, external to the animal’s body. SuperMeat is set to revolutionize the meat industry from its core, aspiring to secure a better future for humans and animals alike. Clean meat is grown in acontrolled, sterile environment without the use of antibiotics and without any possibility of fecal contamination, such as salmonella. Clean meat will require significantly less resources for its production (99% less land, 90% less water), making it both a healthy and sustainable food source for the coming century.
• Meatly — Good Dog Food creates cultivated meat for healthy pets and a healthy planet

Portfolio highlights

• Immitra Bio — Developing scalable in-vivo genomic medicine for blood disorders
• Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
• Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and

Portfolio highlights

• Filuta AI — Operationalized Composite Artificial Intelligence
• Resistell AG — Resistell is a antibiotic resistance test.
• iThera Medical — Explore optoacoustic imaging technology for non-invasive in vivo visualization and quantification of disease-related tissue biomarkers.

Portfolio highlights

• SIRION BIOTECH — Viral Vector Technology as key enabler for innovative therapeutics. Viral vectors are a tool commonly used by molecular biologists to deliver genetic material into cells. This technique enables research of gene function and innovative therapeutics designed to correct defective genes and cancer. These technologies also assist in the discovery ofnew drug, food and cosmetic compounds. SIRION is a global leader in viral vector technology for gene modification of mammalian cells. Along with custom services, the company stands ready to outlicense its unique technologies. An initial target currently being pursued by one of SIRION's partners is a gene therapeutic for cervical cancer. The company started business in 2007 and since then has been changing the paradigm of viral vector supplies. Specifically, all commonly applied vector types are now available within a matter of weeks - adenovirus, adeno-associated virus (AAV) and lentivirus - and a full range of virus related services is at your fingertips spanning from particle production to virus driven cell modelling, all at highest titers and in quantities required for preclinical, clinical and animal testing.The company is easily accessible with presence in Munich, Tokyo, New Hampshire and Tel Aviv. Commercial arrangements range from fee-for-service over exclusive rights on single clones all the way to milestone & licensing arrangements. The business model proves successful: an annual 70% growth since 2007 and experienced in more than 500 projects for both the academic and industry sector.The company is privately held and has over the years raised funds from 8 investors both private and government. In order to support further growth and to benefit from technology development in this exciting industry, the company welcomes new investors. Please contact Management for further information about the company and its future plans.
• CryoTherapeutics — CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intendsto extend the benefits of cryoenergy to the problem of diseased coronary arteries.
• Chundsell Medicals — Chundsell Medicals AB was founded in 2007 as a spin off from Karolinska Institutet, Solna, in order to commercialize the research results of Chunde Li and his group on prostate cancer genomics. The first product: The Prostatype® Test System can assess prostate cancer aggressiveness in conjunction with currently used clinical parameters. TheProstatype® Test System measures the expression pattern of three selected and specific prostate cancer embryonic stem cell genes in tumor cell tissue specimens. These expression patterns together with a group of a selected number of known clinical parameters will help the health care professional to predict the disease outcome, the overall survival as well as cancer specific survival of patients.

Portfolio highlights

• Enzo — Enzo is a Heidelberg based InsurTech startup offering modern and smart insurance coverage for homeowners. Instead of just reacting to claims, Enzo takes a proactive customer-focused approach to prevent damages from happening at all. Thus, Enzo is leading a paradigm shift in a €100+ billion market that has barely improved customer experience forover 100 years. Our Goal is to become Europe's smartest homeowners insurance.
• Primogene —
• Tokura — Tokura focused on redesigning outpatient surgery (Ambulantes Operieren) through an integrated system of specialised facilities, experienced teams, and automated technology.

Portfolio highlights

• Innolume — Innolume is a semiconductor laser fab for GaAs quantum dot and quantum well diode lasers, serving photonics, research and industrial projects.
• Protagen — Protagen is a precision medicine specialist that support drug development, facilitate treatment strategies and improve patient management. Protagen is at the forefront of immuno-profiling and the discovery of novel autoantibody signatures for autoimmune disease and immuno-oncology. Protagen’s SeroTag® technology identifies biomarkers that address anumber of challenges currently hindering the successful development and broader application of both cancer immunotherapies and novel treatments for autoimmune diseases.The company is a leader in patient stratification for autoimmune disease, having developed disease-specific NavigAID stratification panels that profile individual patient’s autoimmune condition and immune status. This precision medicine approach allows for the development and implementation of more targeted therapies for diseases such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), Sjögren’s syndrome (SjS) and others.
• Scienion — Provider of advanced biotech instruments, specializing in precision microdispensing and solutions for single-cell and 3D cellular model sorting and isolation.